RT @Cardio_Pharm_JP: ARNIは、HFrEFの原因疾患が虚血性心疾患か否かで有効性に差は無い。 PARADIGM-HFサブ解析 https://t.co/uW3TDsVEYe
RT @Cardio_Pharm_JP: ARNIは、HFrEFの原因疾患が虚血性心疾患か否かで有効性に差は無い。 PARADIGM-HFサブ解析 https://t.co/uW3TDsVEYe
RT @Cardio_Pharm_JP: ARNIは、HFrEFの原因疾患が虚血性心疾患か否かで有効性に差は無い。 PARADIGM-HFサブ解析 https://t.co/uW3TDsVEYe
ARNIは、HFrEFの原因疾患が虚血性心疾患か否かで有効性に差は無い。 PARADIGM-HFサブ解析 https://t.co/uW3TDsVEYe
Outcomes and Effect of Treatment According to Etiology in HFrEF: An An... https://t.co/EnkzYDOGve
RT @IlindelatorreMD: Resultados y efecto del tratamiento según la etiología en HFrEF : un análisis de PARADIGM-HF | JACC https://t.co/q8LeY…
RT @IlindelatorreMD: Resultados y efecto del tratamiento según la etiología en HFrEF : un análisis de PARADIGM-HF | JACC https://t.co/q8LeY…
Para cardiólogos y afines 🙂
Resultados y efecto del tratamiento según la etiología en HFrEF : un análisis de PARADIGM-HF | JACC https://t.co/q8LeYpX0ei https://t.co/Et5n4KRAej
Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF. Adjusted outcomes were similar across etiologic categories, as was the benefit of sacubitril/valsartan over enalapril. https://t.co/Jl4BaYGToB #nephtwitter #Cardio
RT @cladelucia: #JACCHF Editors' Insights: Sacubitril-Valsartan have a consistent beneficial effect across HFrEF etiologies, and patients w…
Sacubitril/Valsartan with consistent beneficial effect across #HFrEF etiologies, and patients with ischemic cardiomyopathy have more comorbidities though similar outcomes. https://t.co/uq1ZBhFc80 #JACCHF https://t.co/bCdaWoDvBQ
RT @cladelucia: #JACCHF Editors' Insights: Sacubitril-Valsartan have a consistent beneficial effect across HFrEF etiologies, and patients w…
RT @cladelucia: #JACCHF Editors' Insights: Sacubitril-Valsartan have a consistent beneficial effect across HFrEF etiologies, and patients w…
RT @cladelucia: #JACCHF Editors' Insights: Sacubitril-Valsartan have a consistent beneficial effect across HFrEF etiologies, and patients w…
#JACCHF Editors' Insights: Sacubitril-Valsartan have a consistent beneficial effect across HFrEF etiologies, and patients with ischemic cardiomyopathy have more comorbidities though similar outcomes. https://t.co/4oRNOxxsf4
RT @JTLLERGO: Adjusted outcomes were similar across etiologic categories of HFrEF, as was the benefit of sacubitril/valsartan over enalapri…
RT @coconnormd: Outcomes and Effect of Treatment According to Etiology in HFrEF | JACC: Heart Failure: Does etiology matter with drug thera…
RT @coconnormd: Outcomes and Effect of Treatment According to Etiology in HFrEF | JACC: Heart Failure: Does etiology matter with drug thera…
RT @coconnormd: Outcomes and Effect of Treatment According to Etiology in HFrEF | JACC: Heart Failure: Does etiology matter with drug thera…
RT @coconnormd: Outcomes and Effect of Treatment According to Etiology in HFrEF | JACC: Heart Failure: Does etiology matter with drug thera…
RT @coconnormd: Outcomes and Effect of Treatment According to Etiology in HFrEF | JACC: Heart Failure: Does etiology matter with drug thera…
RT @JTLLERGO: Adjusted outcomes were similar across etiologic categories of HFrEF, as was the benefit of sacubitril/valsartan over enalapri…
RT @coconnormd: Outcomes and Effect of Treatment According to Etiology in HFrEF | JACC: Heart Failure: Does etiology matter with drug thera…
RT @coconnormd: Outcomes and Effect of Treatment According to Etiology in HFrEF | JACC: Heart Failure: Does etiology matter with drug thera…
RT @coconnormd: Outcomes and Effect of Treatment According to Etiology in HFrEF | JACC: Heart Failure: Does etiology matter with drug thera…
RT @coconnormd: Outcomes and Effect of Treatment According to Etiology in HFrEF | JACC: Heart Failure: Does etiology matter with drug thera…
RT @coconnormd: Outcomes and Effect of Treatment According to Etiology in HFrEF | JACC: Heart Failure: Does etiology matter with drug thera…
RT @coconnormd: Outcomes and Effect of Treatment According to Etiology in HFrEF | JACC: Heart Failure: Does etiology matter with drug thera…
RT @coconnormd: Outcomes and Effect of Treatment According to Etiology in HFrEF | JACC: Heart Failure: Does etiology matter with drug thera…
RT @JTLLERGO: Adjusted outcomes were similar across etiologic categories of HFrEF, as was the benefit of sacubitril/valsartan over enalapri…
RT @coconnormd: Outcomes and Effect of Treatment According to Etiology in HFrEF | JACC: Heart Failure: Does etiology matter with drug thera…
Outcomes and Effect of Treatment According to Etiology in HFrEF | JACC: Heart Failure: Does etiology matter with drug therapy ? https://t.co/Rb70RFvUFk
RT @JTLLERGO: Adjusted outcomes were similar across etiologic categories of HFrEF, as was the benefit of sacubitril/valsartan over enalapri…
RT @JTLLERGO: Adjusted outcomes were similar across etiologic categories of HFrEF, as was the benefit of sacubitril/valsartan over enalapri…
RT @JTLLERGO: Adjusted outcomes were similar across etiologic categories of HFrEF, as was the benefit of sacubitril/valsartan over enalapri…
RT @JTLLERGO: Adjusted outcomes were similar across etiologic categories of HFrEF, as was the benefit of sacubitril/valsartan over enalapri…
Adjusted outcomes were similar across etiologic categories of HFrEF, as was the benefit of sacubitril/valsartan over enalapril. An Analysis of PARADIGM-HF @JACCJournals @secardiologia @SACardiologia https://t.co/nB1J3qfQv3 https://t.co/71P3J4jZsB
RT @rbarvil: Outcomes and Effect of Treatment According to Etiology in HFrEF | JACC: Heart Failure....👉and what about genetic cardiomyopath…
RT @IcyfaSemi: Interesting article "Outcomes and Effect of Treatment According to Etiology in HFrEF:An Analysis of PARADIGM-HF #SEMITuit @…
RT @IcyfaSemi: Interesting article "Outcomes and Effect of Treatment According to Etiology in HFrEF:An Analysis of PARADIGM-HF #SEMITuit @…
RT @IcyfaSemi: Interesting article "Outcomes and Effect of Treatment According to Etiology in HFrEF:An Analysis of PARADIGM-HF #SEMITuit @…
RT @IcyfaSemi: Interesting article "Outcomes and Effect of Treatment According to Etiology in HFrEF:An Analysis of PARADIGM-HF #SEMITuit @…
RT @IcyfaSemi: Interesting article "Outcomes and Effect of Treatment According to Etiology in HFrEF:An Analysis of PARADIGM-HF #SEMITuit @…
RT @IcyfaSemi: Interesting article "Outcomes and Effect of Treatment According to Etiology in HFrEF:An Analysis of PARADIGM-HF #SEMITuit @…
Interesting article "Outcomes and Effect of Treatment According to Etiology in HFrEF:An Analysis of PARADIGM-HF #SEMITuit @FormigaFrancesc @MiguelCamafort @mendez_bailon @alvarogfranco @chemachir @jopesilver https://t.co/UxFZU1nRJC
RT @coconnormd: Outcomes and Effect of Treatment According to Etiology in HFrEF | JACC: Heart Failure Does etiology matter in drug trials?…
RT @coconnormd: Outcomes and Effect of Treatment According to Etiology in HFrEF | JACC: Heart Failure Does etiology matter in drug trials?…
RT @coconnormd: Outcomes and Effect of Treatment According to Etiology in HFrEF | JACC: Heart Failure Does etiology matter in drug trials?…
RT @coconnormd: Outcomes and Effect of Treatment According to Etiology in HFrEF | JACC: Heart Failure Does etiology matter in drug trials?…
RT @coconnormd: Outcomes and Effect of Treatment According to Etiology in HFrEF | JACC: Heart Failure Does etiology matter in drug trials?…
Outcomes and Effect of Treatment According to Etiology in HFrEF | JACC: Heart Failure Does etiology matter in drug trials? https://t.co/wBsBtWcWps
RT @doctorchecho: El beneficio de Sacubitrilo/Valsartán no se modifica con la etiología de la miocardiopatía. https://t.co/T2u5Dldos5
Outcomes and Effect of Treatment According to Etiology in HFrEF | JACC: Heart Failure....👉and what about genetic cardiomyopathy??”It was not possible to examine outcomes in nonischemic etiologic categories other than the idiopathic because small numbers” h
RT @doctorchecho: El beneficio de Sacubitrilo/Valsartán no se modifica con la etiología de la miocardiopatía. https://t.co/T2u5Dldos5
RT @doctorchecho: El beneficio de Sacubitrilo/Valsartán no se modifica con la etiología de la miocardiopatía. https://t.co/T2u5Dldos5
RT @doctorchecho: El beneficio de Sacubitrilo/Valsartán no se modifica con la etiología de la miocardiopatía. https://t.co/T2u5Dldos5
RT @doctorchecho: El beneficio de Sacubitrilo/Valsartán no se modifica con la etiología de la miocardiopatía. https://t.co/T2u5Dldos5
RT @doctorchecho: El beneficio de Sacubitrilo/Valsartán no se modifica con la etiología de la miocardiopatía. https://t.co/T2u5Dldos5
RT @doctorchecho: El beneficio de Sacubitrilo/Valsartán no se modifica con la etiología de la miocardiopatía. https://t.co/T2u5Dldos5
El beneficio de Sacubitrilo/Valsartán no se modifica con la etiología de la miocardiopatía. https://t.co/T2u5Dldos5